Drug Markets/Suzetrigine

Suzetrigine

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Suzetrigine is used to treat acute pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Jan 30, 2025.

Suzetrigine is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $15.41 to $15.41 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$15.41 – $15.41

per EA

7d Activity

2 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing SUZETRIGINE

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
JOURNAVX 50 MG TABLET
$15.4130
per EA
—
JOURNAVX 50 MG TABLET
$15.4130
per EA
—

Frequently Asked Questions

What is Suzetrigine used to treat?

Suzetrigine is used to treat acute pain, per the National Library of Medicine's MED-RT classification.

How many Suzetrigine products are on the market?

The Suzetrigine drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Suzetrigine?

NADAC reference prices for Suzetrigine range from $15.4130 to $15.4130 per EA.

Which manufacturers make Suzetrigine?

1 manufacturer lists Suzetrigine in NADAC. Ranked by number of NDCs, the largest are Vertex Pharmaceuticals Incorporated (2).